Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SNGX

Soligenix (SNGX)

Soligenix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNGX
DateTimeSourceHeadlineSymbolCompany
12/16/20247:30AMPR Newswire (US)Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
12/13/20245:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20244:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/02/20247:30AMPR Newswire (US)HyBryte™ Clinical Results Demonstrate Continued Improvement Post-TreatmentNASDAQ:SNGXSoligenix Inc
11/19/20247:30AMPR Newswire (US)Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
11/14/20247:15AMPR Newswire (US)Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's DiseaseNASDAQ:SNGXSoligenix Inc
11/08/20244:14PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20244:12PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20244:10PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
11/08/20247:30AMPR Newswire (US)Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial ResultsNASDAQ:SNGXSoligenix Inc
10/24/20247:30AMGlobeNewswire Inc.Soligenix, Inc. to Present at the 2024 ThinkEquity ConferenceNASDAQ:SNGXSoligenix Inc
10/22/20247:30AMPR Newswire (US)Soligenix Receives Hong Kong Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
10/16/20247:30AMPR Newswire (US)Soligenix Invited to Present at Upcoming Investor ConferencesNASDAQ:SNGXSoligenix Inc
10/11/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
10/07/20247:30AMPR Newswire (US)HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer ConferenceNASDAQ:SNGXSoligenix Inc
10/03/20247:30AMPR Newswire (US)Soligenix Announces Partnership with Sterling Pharma SolutionsNASDAQ:SNGXSoligenix Inc
09/16/20247:30AMPR Newswire (US)Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024NASDAQ:SNGXSoligenix Inc
09/03/20247:30AMPR Newswire (US)Soligenix Receives European Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
08/16/20244:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SNGXSoligenix Inc
08/16/20244:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
08/09/20244:09PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
08/09/20244:07PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
08/09/20244:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
 Showing the most relevant articles for your search:NASDAQ:SNGX

Your Recent History

Delayed Upgrade Clock